Designer drugs from designer bugs

被引：0

|

作者：

Weissman, K ^{[1
]}

机构：

[1] Univ Cambridge, Cambridge CB2 1TN, England

来源：

CHEMISTRY & INDUSTRY | 1998年 / 13期

关键词：

D O I：

暂无

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

引用

收藏

页码：519 / 521

页数：3

相关论文

共 50 条

[21] NEUROLOGIC CONSEQUENCES OF DESIGNER DRUGS
LANGSTON, JW
[J]. WESTERN JOURNAL OF MEDICINE, 1987, 146 (03): : 351 - 351
[22] Designer drugs as a cause of homicide
Matsumoto, Toshihiko
Okada, Takayuki
[J]. ADDICTION, 2006, 101 (11) : 1666 - 1667
[23] The new word in designer drugs
不详
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7149): : 1930 - 1930
[24] DESIGNER DRUGS HEAD FOR THE MARKETPLACE
BLUNDELL, T
[J]. NEW SCIENTIST, 1990, 126 (1720) : 61 - 64
[25] Bioanalysis of new designer drugs
Wohlfarth, Ariane
Weinman, Wolfgang
[J]. BIOANALYSIS, 2010, 2 (05) : 965 - 979
[26] Piperazine designer drugs of abuse
Staack, Roland F.
[J]. LANCET, 2007, 369 (9571): : 1411 - 1413
[27] DESIGNER DRUGS - THE WHATS AND THE WHYS
CHESHER, G
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1990, 153 (03) : 157 - 161
[28] DESIGNER DRUGS - KIRSCH,MM
HARLOW, D
[J]. AMERICAN BOOK REVIEW, 1989, 11 (05) : 6 - +
[29] Designer drugs: the biologic therapies
Johnston, Sarah
[J]. CLINICAL MEDICINE, 2006, 6 (04) : 337 - 343
[30] Designer drugs in the general hospital
Bialer, PA
[J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 2002, 25 (01) : 231 - +

← 1 2 3 4 5 →